Cohen-led team concludes phenibut warnings had no deterrent effect
A research team led by prominent industry critic Dr Pieter Cohen has found that FDA warning letters sent to companies using phenibut in dietary supplements didn’t prevent other firms from continuing to use the illegal ingredient.